Tailored Drug Cocktails Offer Hope to Kids with Aggressive Brain Tumors
By creating a tailored drug cocktail that matches the mutations of a brain tumor, a new precision medicine approach may move the needle for children with high-grade gliomas.
University of California San Francisco
Give to UCSFBy creating a tailored drug cocktail that matches the mutations of a brain tumor, a new precision medicine approach may move the needle for children with high-grade gliomas.
Dignity Health and UCSF Health are collaborating to develop a state-of-the-art digital engagement platform that will provide information and access to patients when and where they need it.
UCSF and a newly formed, next-generation nonprofit organization, Health Hub, are announcing their plans to affiliate.
UCSF researchers have identified a key biological pathway in human cancer patients that appears to prime the immune system for a successful response to immunotherapy drugs – checkpoint inhibitors.
Teens like Anthony Orosco are using their creative juices to change the conversation about Type 2 diabetes, thanks to a partnership between UCSF and arts nonprofit Youth Speaks.
Silicon Valley is helping researchers like Wendell Lim move basic science breakthroughs into translational applications, making treatments available to patients faster than normally possible.
Samsung Electronics Co., Ltd. and UCSF have announced the launch of My BP Lab, a jointly developed smartphone research app to help users monitor their blood pressure and stress levels.
A new UCSF study has shown that a cancer-killing (“oncolytic”) virus currently in clinical trials may function as a cancer vaccine.
UCSF neurologists have discovered monthly cycles of brain activity linked to seizures in patients with epilepsy.
Stephanie Marrus, director of the UCSF Entrepreneurship Center, is among 150 invited speakers at the 2017 Global Entrepreneurship Summit.
New research finds one of the world’s most deadly forms of lung cancer is driven by changes in multiple different genes.
One of UCSF’s groundbreaking cancer programs will be prominently featured at the 2017 Dreamforce conference through an interactive exposition and a talk by two researchers.
Scientists from two U.S. national laboratories, industry, and academia on Oct. 27 launched an unprecedented effort to transform the way cancer drugs are discovered.